Imagery |
|
|
Clinical Trial: Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin's Lymphoma
Music Imagery for Patients Receiving Chemotherapy for Leukemia or Non-Hodgkin’s Lymphoma
This study has been completed.
|
Purpose
The purpose of this study is to explore the effect of music imagery on patients receiving intensive chemotherapy for acute leukemia or high-grade non-Hodgkin’s lymphoma.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Leukemia Lymphoma, Non-Hodgkin | Behavior: Music Imagery | Phase I Phase II |
MedlinePlus related topics: Leukemia, Adult Acute; Leukemia, Adult Chronic; Leukemia, Childhood; Lymphoma
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Music Imagery for Patients in Protected Environments
Expected Total Enrollment: 60
Study start: July 2002
Standard treatment for acute leukemia and high-grade non-Hodgkin’s lymphoma includes intensive chemotherapy that typically requires a 4-week hospital stay in protective isolation. Patients treated in isolation units may experience elevated levels of psychological distress. Both guided imagery and music therapy have been effective in improving the moods of cancer patients, but studies have not been conducted in acute leukemia and non-Hodgkin’s lymphoma patients. This study will evaluate the effect of music imagery on these patients.
Participants in this study will be randomly assigned to receive either standard care plus music imagery or standard care alone. Participants assigned to the standard care plus music imagery group will receive a 45-minute weekly music imagery session with a music therapist. All participants will complete questionnaires and self-reports regarding their general anxiety, affect, and fatigue.
Eligibility
Ages Eligible for Study: 18 Years - 80 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Admitted to Indiana University Hematologic Malignancy Program for the treatment of newly diagnosed or recurrent acute leukemia or high-grade non-Hodgkin’s lymphoma
- Able to read and understand English
Location Information
Indiana
Indiana University Cancer Center/University Hospital, Indianapolis, Indiana, 46202, United States
More Information
Record last reviewed: March 2005
Last Updated: March 2, 2005
Record first received: May 5, 2004
ClinicalTrials.gov Identifier: NCT00082303
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Not Signed In -


